Results 21 to 30 of about 376,110 (130)

The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysis [PDF]

open access: yesRenal Failure, 2023
Severe rhabdomyolysis frequently results in acute kidney injury (AKI) due to myoglobin accumulation with the need of kidney replacement therapy (KRT). The present study investigated whether the application of Cytosorb® (CS) led to an increased rate of ...
Caroline Gräfe   +9 more
doaj   +2 more sources

Pilot study: In vitro reduction of hemoglobin from canine blood with hemoperfusion using the Cytosorb® adsorber. [PDF]

open access: yesPLoS ONE
Cell-free hemoglobin (cfHb) can be toxic and lead to kidney injury. This study assessed the in vitro reduction of cfHb from canine hemolyzed blood using hemoperfusion with a Cytosorb® cytokine adsorber.
Kathrin Spiegel   +3 more
doaj   +2 more sources

A rare case of acute liver failure with intrahepatic cholestasis due to dengue hemorrhagic fever: CytoSorb® and plasma exchange aided in the recovery: case report [PDF]

open access: yesBMC Infectious Diseases, 2022
Background Dengue haemorrhagic fever is a severe form of acute dengue infection characterized by leakage of plasma through capillaries into body spaces resulting in circulatory insufficiency leading to shock.
Arosha Minori Gunasekera   +3 more
doaj   +2 more sources

CytoSorb haemoadsorption in critically ill children: a multicentre observational study on feasibility, safety, and outcomes, the CYTOPED study [PDF]

open access: yesAnnals of Intensive Care
Introduction: CytoSorb® is a cartridge for the adsorption of inflammatory mediators, bilirubin, myoglobin and other xenobiotics, directly from the blood stream.
Gabriella Bottari   +15 more
doaj   +2 more sources

Cytokine hemoadsorption with CytoSorb® in patients with sepsis: a systematic review and meta-analysis. [PDF]

open access: yesCrit Care Sci, 2023
Objective: To analyze the effect of CytoSorb® on mortality, interleukin levels, vasopressor use and adverse events in patients with sepsis. Methods: We searched MEDLINE®, Embase and the Cochrane Library for randomized controlled trials and cohort studies
Saldaña-Gastulo JJC   +3 more
europepmc   +2 more sources

Hemadsorption with Adult CytoSorb® in a Low Weight Pediatric Case

open access: yesCase Reports in Critical Care, 2017
Cytokine adsorber (CytoSorb) has been used successfully as adjunctive treatment for adult patients with elevated cytokine levels in the setting with severe sepsis and septic shock and to reduce blood myoglobin, unconjugated bilirubin, and conjugated ...
Catalin Gabriel Cirstoveanu   +2 more
doaj   +2 more sources

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

open access: yesCase Reports in Cardiology, 2019
A 67-year-old woman with a history of end-stage renal disease on hemodialysis received a therapeutic dose (150 mg daily) of flecainide for three weeks.
Nicolas De Schryver   +3 more
doaj   +2 more sources

Revolutionizing Severe Malaria Management: The Role of CytoSorb® Hemoadsorption in Treating Malaria-Induced Liver Dysfunction. [PDF]

open access: yesCureus
: Malaria, caused by Plasmodium falciparum (PF), can lead to severe liver dysfunction and hyperbilirubinemia, worsening the prognosis. A 53-year-old male patient with malaria-related liver dysfunction and severe hyperbilirubinemia was treated with ...
De Rosa RC   +4 more
europepmc   +2 more sources

Effective Treatment of Acute Tricyclic Antidepressant Poisoning with Cardiogenic Shock and Severe Rhabdomyolysis Using ECMO and CytoSorb® Adsorber. [PDF]

open access: yesAm J Case Rep, 2023
BACKGROUND Tricyclic antidepressant (TCA) drugs are a common cause of fatal poisoning because of their cardiotoxic and arrhythmogenic effects. Classic supportive management includes sodium bicarbonate, gastrointestinal chelating agents, and vasopressors.
Zitoune Z   +6 more
europepmc   +2 more sources

CytoSorb® usage in a dual antiplatelet agent treated patient during CABG and broken guidewire retrieval from right coronary artery ostium [PDF]

open access: yesInternational Journal of Medical Device and Adjuvant Treatments, 2022
Objective: We report a case of a patient undergoing Open Coronary Artery Bypass Graft Surgery (CABG) with CytoSorb® under dual antiplatelet therapy (DAPT) with a broken guidewire in RCA ostium.
N. Kumar, V. Keshri, R. Bhuyan
doaj   +1 more source

Home - About - Disclaimer - Privacy